CD86 and cancer: Immune checkpoint inhibition is a mechanism that inhibits the expression of immune checkpoint proteins, such as PD-1/PD-L1 and cytotoxic T-lymphocyte antigen (CTLA)-4/B7-1/B7-2, expressed on T cells or cancer cells.